Regorafenib for Gastrointestinal Stromal Tumor User Reviews
Brand names: Stivarga
Regorafenib has an average rating of 6.3 out of 10 from a total of 3 reviews for the treatment of Gastrointestinal Stromal Tumor. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
- Harish
- September 9, 2015
Stivarga (regorafenib) "Only side effects and no result"
- jasper
- Taken for 1 to 2 years
- August 9, 2021
"I have been on stivarga for 18 months. few side effects and tumor has shrunk in half and continues to shrink."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about regorafenib
- Check interactions
- Compare alternatives
- Reviews (14)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Stivarga (regorafenib) "I have been on Stivarga for 3 years. It has stopped the growth of GIST mild side effects. Take 120 mg every night at 11:00 p.m."